Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR detection and cell function

Radiology

Volumn 243, Issue 2, 2007, Pages 467-474

  Oude Engberink, Raoul D ^a   Van Der Pol, Susanne M A ^b   Döpp, Ed A ^b   De Vries, Helga E ^b   Blezer, Erwin L A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC FERROCYANIDE; INTERLEUKIN 1; INTERLEUKIN 6; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ANALYSIS OF VARIANCE; ARTICLE; BRAIN CELL; CALCULATION; CELL FUNCTION; CELL ISOLATION; CELL LABELING; CELL MIGRATION; CELL VIABILITY; CONCENTRATION (PARAMETERS); CULTURE MEDIUM; CYTOKINE PRODUCTION; DATA ANALYSIS; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOCYTE; NUCLEAR MAGNETIC RESONANCE; PARTICLE SIZE; PRIORITY JOURNAL; STAINING; STUDENT T TEST;

CELL MOVEMENT; CELL SURVIVAL; CONTRAST MEDIA; CYTOKINES; HUMANS; IMMUNOLOGIC FACTORS; IRON; MONOCYTES; OXIDES; PARTICLE SIZE; STAINING AND LABELING;

EID: 34247486871     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2432060120     Document Type: Article

References (30)

1. Al-Omaishi J, Bashir R, Gendelman HE. The cellular immunology of multiple sclerosis. J Leukoc Biol 1999;65:444-452.
2. de Vries HE, Kuiper J, de Boer AG, Van Berkel TJ, Breimer DD. The blood-brain barrier in neuroinflammatory diseases. Pharmacol Rev 1997;49:143-155.
3. Bruck W, Sommermeier N, Bergmann M, et al. Macrophages in multiple sclerosis. Immunobiology 1996;195:588-600.
4. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990;175: 489-493.
5. Dousset V, Delalande C, Ballarino L, et al. In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance. Magn Reson Med 1999;41:329-333.
6. Rausch M, Hiestand P, Baumann D, Cannet C, Rudin M. MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE. Magn Reson Med 2003;50:309-314.
7. Floris S, Blezer EL, Schreibelt G, et al. Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. Brain 2004;127:616-627.
8. Zelivyanskaya ML, Nelson JA, Poluektova L, et al. Tracking superparamagnetic iron oxide labeled monocytes in brain by high-field magnetic resonance imaging. J Neurosci Res 2003;73:284-295.
9. Sipe JC, Filippi M, Martino G, et al. Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agents. Magn Reson Imaging 1999;17: 1521-1523.
10. Metz S, Bonaterra G, Rudelius M, Settles M, Rummeny EJ, Daldrup-Link HE. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur Radiol 2004;14:1851-1858.
11. Benderbous S, Corot C, Jacobs P, Bonnemain B. Superparamagnetic agents: physicochemical characteristics and preclinical imaging evaluation. Acad Radiol 1996;3(suppl 2):S292-S294.
12. Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001;11: 2319-2331.
13. Jung CW. Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 1995;13:675-691.
14. Van der Goes A, Wouters D, Van Der Pol SM, et al. Reactive oxygen species enhance the migration of monocytes across the bloodbrain barrier in vitro. FASEB J 2001;15: 1852-1854.
15. Floris S, Ruuls SR, Wierinckx A, et al. Interferon-beta directly influences monocyte infiltration into the central nervous system. J Neuroimmunol 2002;127:69-79.
16. Hendriks JJ, Alblas J, van der Pol SM, van Tol EA, Dijkstra CD, de Vries HE. Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis. J Exp Med 2004;200:1667-1672.
17. Daldrup-Link HE, Rudelius M, Oostendorp RA, et al. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology 2003;228:760-767.
18. Matuszewski L, Persigehl T, Wall A, et al. Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency. Radiology 2005;235:155-161.
19. Raynal I, Prigent P, Peyramaure S, Najid A, Rebuzzi C, Corot C. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest Radiol 2004;39:56-63.
20. Rausch M, Sauter A, Frohlich J, Neubacher U, Radu EW, Rudin M. Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage. Magn Reson Med 2001;46:1018-1022.
21. Saleh A, Schroeter M, Jonkmanns C, Hartung HP, Modder U, Jander S. In vivo MRI of brain inflammation in human ischaemic stroke. Brain 2004;127:1670-1677.
22. Dousset V, Brochet B, Caille JM, Petry KG. Enhancement of multiple sclerosis lesions with ultra-small particle iron oxide: phase II study [abstr]. In: Proceedings of the Ninth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2001; 261.
23. McLachlan SJ, Morris MR, Lucas MA, et al. Phase 1 clinical evaluation of a new iron oxide MR contrast agent. J Magn Reson Imaging 1994;4:301-307.
24. Weissleder R, Stark DD, Engelstad BL, et al. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol 1989;152:167-173.
25. Oweida A, Dunn E, Foster P. Cellular imaging of neuroinflammation: a novel method for unraveling the roles of macrophages populations in EAE [abstr]. In: Proceedings of the Thirteenth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2005; 519.
26. Arbab AS, Yocum GT, Wilson LB, et al. Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability. Mol Imaging 2004;3:24-32.
27. Ericsson A, Lonnemark M, Hemmingsson A, Bach-Gansmo T. Effect of superparamagnetic particles in agarose gels: a magnetic resonance imaging study. Acta Radiol 1991; 32:74-78.
28. Hickey WF. Leukocyte traffic in the central nervous system: the participants and their roles. Semin Immunol 1999;11:125-137.
29. Bauer J, Huitinga I, Zhao W, Lassmann H, Hickey WF, Dijkstra CD. The role of macrophages, perivascular cells, and microglial cells in the pathogenesis of experimental autoimmune encephalomyelitis. Glia 1995;15: 437-446.
30. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003;3:23-35.